1. Home
  2. SB vs PHAT Comparison

SB vs PHAT Comparison

Compare SB & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safe Bulkers Inc ($0.001 par value)

SB

Safe Bulkers Inc ($0.001 par value)

HOLD

Current Price

$8.84

Market Cap

773.9M

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$7.44

Market Cap

676.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SB
PHAT
Founded
2007
2018
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
773.9M
676.3M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
SB
PHAT
Price
$8.84
$7.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$6.00
$19.83
AVG Volume (30 Days)
1.3M
1.0M
Earning Date
05-18-2026
04-30-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
$3.47
$93.04
Revenue Next Year
$3.61
$58.91
P/E Ratio
$16.77
N/A
Revenue Growth
N/A
216.93
52 Week Low
$4.14
$7.47
52 Week High
$9.31
$18.31

Technical Indicators

Market Signals
Indicator
SB
PHAT
Relative Strength Index (RSI) 56.28 31.91
Support Level $6.20 N/A
Resistance Level $9.31 $9.74
Average True Range (ATR) 0.33 0.47
MACD -0.02 -0.13
Stochastic Oscillator 59.83 4.75

Price Performance

Historical Comparison
SB
PHAT

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: